ROX Index for Intubation after HFNC
ورودیهای بالینی بیمار
حداقل ۷۰ — حداکثر ۱۰۰ • واحد: %
حداقل ۰.۲۱ — حداکثر ۱ • واحد: fraction
حداقل ۱۰ — حداکثر ۵۰ • واحد: breaths/min
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- High Risk for HFNC Failure0–3.84
- Indeterminate Risk3.85–4.87
- Lower Risk for Intubation4.88–20
Clinical Decision Pathway
Clinical Decision Pathway & Next Steps
Respiratory & Pneumonia — بیماریهای تنفسی، پنومونی و COPD
Clinical Rationale:
Stratify community-acquired pneumonia with CURB-65 and PSI/PORT; monitor ROX during high-flow oxygen for intubation avoidance, and guide acute COPD exacerbation with BAP-65, DECAF, and GOLD criteria.
PSI/PORT Score: Pneumonia Severity Index for CAP
شاخص شدت پنومونی PSI/PORT
Recommended Clinical Next Steps:
BAP-65 Score for Acute Exacerbation of COPD
امتیاز BAP-65 (تشدید حاد COPD)
Why next: Mortality and mechanical ventilation in COPDDECAF Score for Acute Exacerbation of COPD
امتیاز DECAF (مرگومیر بستری در COPD)
Why next: In-hospital mortality prediction in acute COPDGlobal Initiative for Obstructive Lung Disease (GOLD) Criteria for COPD
معیارهای GOLD برای شدت COPD
Why next: Airflow limitation severity staging by post-BD FEV1
The ROX Index for Intubation after HFNC calculator is designed for bedside predicting high-flow nasal cannula (HFNC) failure and need for intubation in patients with acute hypoxemic respiratory failure in clinical practice. The resulting score directly guides clinician decision-making regarding determining acute hospital admission, emergency.
Clinical Guidelines & Evidence
Predicts high-flow nasal cannula (HFNC) failure and need for intubation in patients with acute hypoxemic respiratory failure. The ROX Index combines oxygen saturation, fraction of inspired oxygen, and respiratory rate to provide early prediction of treatment success or failure, helping clinicians make timely decisions about escalation of care to avoid delayed intubation and associated complications.
Clinical Indication
The ROX Index for Intubation after HFNC is indicated for bedside clinical practice to support Predicts high-flow nasal cannula (HFNC) failure and need for intubation in patients with acute hypoxemic respiratory failure. The ROX Index combines oxygen saturation, fraction of inspired oxygen, and respiratory rate to provide early prediction of treatment success or failure, helping clinicians make timely decisions about escalation of care to avoid delayed intubation and associated complications.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult and pediatric patients presenting with acute undifferentiated clinical complaints, trauma, or unstable vital signs. Clinical application is indicated across Emergency triage, acute resuscitation bays, observation units, and emergency trauma centers.
Limitations & Contraindications
Score calculations must never delay immediate life-saving airway stabilization, vascular access, or emergent surgical consult.
Clinical Pearls & Action Plan
Adherence to core ABCDE resuscitation principles and bedside clinical gestalt must take absolute precedence over numerical decision tools. Guideline pearl: ROX <3.85 has 98-99% specificity for predicting HFNC failure when measured <12 hours.
ROX Index = (SpO2/FiO2 × 100) / Respiratory Rate, where SpO2 is oxygen saturation (%), FiO2 is fraction of inspired oxygen (0.21-1.0), and Respiratory Rate is breaths per minute
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| spo2 | integer | Yes | Pulse oximetry oxygen saturation measured on current HFNC settings(%) |
| fio2 | float | Yes | Fraction of inspired oxygen being delivered by HFNC (0.21-1.0)(fraction) |
| respiratory_rate | integer | Yes | Current respiratory rate in breaths per minute(breaths/min) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–3.84 | High Risk for HFNC Failure | Early intubation consideration |
| 3.85–4.87 | Indeterminate Risk | Reassess in 1-2 hours |
| 4.88–20 | Lower Risk for Intubation | Continue HFNC and wean FiO2 |
Evidence-Based References (EBM)
- Roca O, Messika J, Caralt B, García-de-Acilu M, Sztrymf B, Ricard JD, Masclans JR. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index. J Crit Care. 2016 Oct;35:200-5. doi: 10.1016/j.jcrc.2016.05.022.DOI: 10.1016/j.jcrc.2016.05.022
- Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernández G, García-de-Acilu M, Frat JP, Masclans JR, Ricard JD. An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy. Am J Respir Crit Care Med. 2019 Jun 1;199(11):1368-1376. doi: 10.1164/rccm.201803-0589OC.DOI: 10.1164/rccm.201803-0589OC
- Suliman LA, Abdelgawad TT, Farrag NS, Abdelwahab HW. Validity of ROX index in prediction of risk of intubation in patients with COVID-19 pneumonia. Adv Respir Med. 2021;89(1):1-6. doi: 10.5603/ARM.a2020.0176.DOI: 10.5603/ARM.a2020.0176